Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Celldex Therapeutics SVPs Engage In Heavy Transactions

TheMotleyFool 
0 0 12.01.26
Celldex Therapeutics SVPs Engage In Heavy Transactions: https://cdn.content.foolcdn.com/images/1umn9qeh/production/6f699693a3501babe6eb40aac5d3061bf74bda96-1401x1251.png?w=1401&h=1251
 

On Dec. 4, 2025, Freddy A. Jimenez, Senior Vice President General Counsel of Celldex Therapeutics (NASDAQ:CLDX), executed an open-market sale of 4,166 insider shares. See SEC Form 4 filing.

Transaction value based on SEC Form 4 reported price ($29.09); post-Transaction value based on Dec. 4, 2025 market close ($29.09).

Continue reading


Source Fool.com

Celldex Therapeutics Stock

€18.90
-7.350%
Heavy losses for Celldex Therapeutics today as the stock fell by -€1.500 (-7.350%).
Currently there is a rather positive sentiment for Celldex Therapeutics with 8 Buy predictions and 3 Sell predictions.
Based on the current price of 18.9 € the target price of 38 € shows a potential of 101.06% for Celldex Therapeutics which would more than double the current price.
Show more
Like: 0
CLDX
Share

Comments

Not a member yet? Sign up for free!